Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
03 Jun, 2026, 02.36 PM IST
Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
30 May, 2026, 11.17 PM IST
Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
29 May, 2026, 05.30 AM IST
Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
29 May, 2026, 12.57 AM IST
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
23 May, 2026, 10.24 PM IST
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
18 May, 2026, 10.31 PM IST
From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
18 May, 2026, 06.40 PM IST
Strait of Hormuz is now India's biggest market risk, says Ashi AnandIndian markets await clarity on Strait of Hormuz shipping. Ashi Anand of IME Capital suggests a defensive market approach. Oil prices near ...
18 May, 2026, 11.56 AM IST
Trump unveils deal with Regeneron to lower drug prices as part of most-favored-nation initiativeRegeneron will reduce prices for its drugs on Medicaid. A cholesterol drug, Praluent, will be available for USD 225 on Trump's discounted d...
24 Apr, 2026, 09.41 AM IST
Iran war impact: Essential drugs may cost up to 5% more, for nowThe immediate net consumer impact could be 3-5% higher prices, or roughly similar to what consumers paid before the late-September cuts in ...
15 Apr, 2026, 06.00 AM IST
Painkiller, antibiotic prices set for marginal increase starting April 1Starting April 1, the prices of essential medicines will experience an increase of 0.6%. This change aligns with the annual alterations in ...
26 Mar, 2026, 12.45 AM IST
Reliance submits proposal for potential Covid drugNiclosamide, a drug on the World Health Organisation's list of essential medicines, has been used to treat tapeworm infestation for more th...
03 Jun, 2021, 05.01 PM IST
DRDO's anti-COVID drug priced at Rs 990 per sachet; Centre, states to get discountsThe first batch of DRDO's anti-Covid-19 drug was released on May 17 by Defence Minister Rajnath Singh and health minister Dr Harsh Vardhan,...
28 May, 2021, 04.12 PM IST
Remdesivir sells at 10x prices, NPPA unable to regulate as it's not notified as a 'drug'The NPPA can only control prices of devices and products that are defined as drugs under the Drugs and Cosmetics Act. A product or device t...
30 Jul, 2020, 09.14 AM IST
Glenmark drops 5% as DCGI seeks clarity on Covid-19 drug, overpricing complaintsThe drug regulator also pulled up Glenmark over the pricing of the drug, after receiving a complaint from a member of Parliament.
20 Jul, 2020, 11.16 AM IST
These are the companies manufacturing COVID-19 drug Remdesivir in India03 Jul, 2020, 08.50 AM IST
Will the launch of Favipiravir mark the turnaround for Glenmark Pharma?If the drug proves to be efficacious for Covid treatment, Glenmark will cash in on first mover advantage.
23 Jun, 2020, 09.33 AM IST